Clinical Trial Update: Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Appatinib in combination with S-1 for small cell lung cancer is underway, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Appatinib
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN